Literature DB >> 27195762

Staphylococcus aureus avirulent mutant vaccine induces humoral and cellular immune responses on pregnant heifers.

M Pellegrino1, N Rodriguez2, A Vivas3, J Giraudo4, C Bogni5.   

Abstract

Bovine mastitis produces economic losses, attributable to the decrease in milk production, reduced milk quality, costs of treatment and replacement of animals. A successful prophylactic vaccine against Staphylococcus aureus should elicit both humoral and cellular immune responses. In a previous report we evaluated the effectiveness of a live vaccine to protect heifers against challenge with a virulent strain. In the present study the immunological response of heifers after combined immunization schedule was investigated. In a first experimental trial, heifers were vaccinated with 3 subcutaneous doses of avirulent mutant S. aureus RC122 before calving and one intramammary dose (IMD) after calving. Antibodies concentration in blood, bactericidal effect of serum from vaccinated animals and lymphocyte proliferation was determined. The levels of total IgG, IgG1 and IgG2 in colostrum and the lymphocyte proliferation index were significantly higher in vaccinated respect to non-vaccinated group throughout the experiment. The second trial, where animals were inoculated with different vaccination schedules, was carried out to determine the effect of the IMD on the level of antibodies in blood and milk, cytokines (IL-13 and IFN-γ) concentration and milk's SCC and bacteriology. The bacterial growth of the S. aureus strains was totally inhibited at 1-3×10(6) and 1-3×10(3)cfu/ml, when the strains were mixed with pooled serum diluted 1/40. The results shown that IMD has not a significant effect on the features determinate. In conclusion, a vaccination schedule involving three SC doses before calving would be enough to stimulate antibodies production in milk without an IMD. Furthermore, the results showed a bactericidal effect of serum from vaccinated animals and this provides further evidence about serum functionality. Immune responses, humoral (antigen-specific antibodies and Th2 type cytokines) and cellular (T-lymphocyte proliferation responses and Th1 type cytokines), were augmented by administration of the avirulent mutant which represent an antigenic pool.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Avirulent mutant; Bovine mastitis; Staphylococcus aureus

Mesh:

Substances:

Year:  2016        PMID: 27195762     DOI: 10.1016/j.vaccine.2016.05.014

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  3 in total

1.  In Vitro Characterization of Lactic Acid Bacteria Isolated from Bovine Milk as Potential Probiotic Strains to Prevent Bovine Mastitis.

Authors:  Matías S Pellegrino; Ignacio D Frola; Berardo Natanael; Dino Gobelli; María E F Nader-Macias; Cristina I Bogni
Journal:  Probiotics Antimicrob Proteins       Date:  2019-03       Impact factor: 4.609

2.  Individual variation is the key to the development of a vaccine against Staphylococcus aureus: a comparative study between mice lineages.

Authors:  D P Dos Santos; I P R Muniz; A F Queiroz; I S Pereira; M P A Souza; L J Lima; L R O Sousa; I S Ribeiro; M P L Galantini; L M Marques; T B Figueiredo; R A A da Silva
Journal:  Braz J Med Biol Res       Date:  2018-03-26       Impact factor: 2.590

3.  Identification of Inflammatory and Regulatory Cytokines IL-1α-, IL-4-, IL-6-, IL-12-, IL-13-, IL-17A-, TNF-α-, and IFN-γ-Producing Cells in the Milk of Dairy Cows with Subclinical and Clinical Mastitis.

Authors:  Zane Vitenberga-Verza; Māra Pilmane; Ksenija Šerstņova; Ivars Melderis; Łukasz Gontar; Maksymilian Kochański; Andżelika Drutowska; Gergely Maróti; Beatriz Prieto-Simón
Journal:  Pathogens       Date:  2022-03-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.